Showing results (341-350 of 498) with videos related to

Sort By:
Pageof 50
Liver International : Official Journal of the International Association for the Study of the Liver|February 17, 2025
Bulevirtide in Chronic Hepatitis D Patients Awaiting Liver Transplantation Results From a French Multicentric Retrospective StudyMagdalena Meszaros, Marie-Noëlle Hilleret, Jérôme Dumortier, et al.
Cancer Research|July 20, 2006
Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancerBalazs Dome, Jozsef Timar, Judit Dobos, et al.
Circulation Research|February 21, 2012
Absence of type VI collagen paradoxically improves cardiac function, structure, and remodeling after myocardial infarctionDaniel J Luther, Charles K Thodeti, Patricia E Shamhart, et al.
Clinical and Experimental Rheumatology|February 16, 2019
The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinibErnest H S Choy, Corinne Miceli-Richard, Miguel A González-Gay, et al.
Journal of Sleep Research|January 8, 2020
Obstructive sleep apnea and hypertriglyceridaemia share common genetic background: Results of a twin studyMartina Meszaros, Adam Domonkos Tarnoki, David Laszlo Tarnoki, et al.
RMD Open|August 21, 2023
Safety profile of baricitinib in patients with systemic lupus erythematosus: an integrated analysisEric Morand, Josef S Smolen, Michelle Petri, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 28, 2011
Endothelin-mediated in vivo pressor responses following TRPV1 activationVahagn A Ohanyan, Giacinta Guarini, Charles K Thodeti, et al.
The Annals of Thoracic Surgery|July 10, 2012
Long-term results after operations for active infective endocarditis in native and prosthetic valvesKatharina Meszaros, Sladjan Nujic, Gottfried H Sodeck, et al.
Frontiers in Pharmacology|April 22, 2022
Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and AngiogenesisGiorgiana Negrea, Valentin-Florian Rauca, Marta Szilvia Meszaros, et al.
Scientific Reports|November 4, 2025
Theranostic application of radiolabeled HER2-targeting single-domain antibodies (RAD202) in preclinical settingBetül Altunay, Luka Obradović, Alexandru Florea, et al.
Pageof 50